These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33972393)

  • 1. Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity.
    Smith ER; Leal J; Amaya C; Li B; Xu XX
    Mol Cell Biol; 2021 Jun; 41(7):e0064820. PubMed ID: 33972393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel resistance related to nuclear envelope structural sturdiness.
    Smith ER; Wang JQ; Yang DH; Xu XX
    Drug Resist Updat; 2022 Dec; 65():100881. PubMed ID: 36368286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis.
    Capo-Chichi CD; Yeasky TM; Smith ER; Xu XX
    BMC Cell Biol; 2016 Nov; 17(1):37. PubMed ID: 27875985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
    Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
    BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking malignant nuclei as a non-mitotic mechanism of taxol/paclitaxel.
    Smith ER; Xu XX
    J Cancer Biol; 2021; 2(4):86-93. PubMed ID: 35048083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
    Lee EA; Keutmann MK; Dowling ML; Harris E; Chan G; Kao GD
    Mol Cancer Ther; 2004 Jun; 3(6):661-9. PubMed ID: 15210851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.
    Wang X; Wu E; Wu J; Wang TL; Hsieh HP; Liu X
    PLoS One; 2013; 8(6):e65686. PubMed ID: 23762410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J; O'brate A; Zelnak A; Giannakakou P
    Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
    Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
    Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
    Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel.
    Ahmed AA; Mills AD; Ibrahim AE; Temple J; Blenkiron C; Vias M; Massie CE; Iyer NG; McGeoch A; Crawford R; Nicke B; Downward J; Swanton C; Bell SD; Earl HM; Laskey RA; Caldas C; Brenton JD
    Cancer Cell; 2007 Dec; 12(6):514-27. PubMed ID: 18068629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viriditoxin Stabilizes Microtubule Polymers in SK-OV-3 Cells and Exhibits Antimitotic and Antimetastatic Potential.
    Su M; Zhao C; Li D; Cao J; Ju Z; Kim E; Jung YS; Jung JH
    Mar Drugs; 2020 Aug; 18(9):. PubMed ID: 32867174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
    Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
    Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
    Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
    Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
    Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
    Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
    Marcus AI; Peters U; Thomas SL; Garrett S; Zelnak A; Kapoor TM; Giannakakou P
    J Biol Chem; 2005 Mar; 280(12):11569-77. PubMed ID: 15653676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.
    George JA; Chen T; Taylor CC
    Cancer Res; 2005 Nov; 65(22):10381-8. PubMed ID: 16288028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs.
    Liao CF; Luo SF; Shen TY; Lin CH; Chien JT; Du SY; Jiang MC
    BMB Rep; 2008 Mar; 41(3):210-6. PubMed ID: 18377724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.